ABOT announcements Abbott Laboratories (Pakistan) Limited
Abbott Laboratories (Pakistan) Limited (ABOT) has 100 notices stored from the exchange, from 26 Aug 2022 to 30 Oct 2026. The newest is dated 30 Oct 2026; the titles below are the exchange’s own words.
Every notice stored, newest first
| Date | Kind | Title as filed | |
|---|---|---|---|
| 30 Oct 2026 | Report sent to shareholders | Transmission of Quarterly Reports for the Period Ended September 30, 2026 | |
| 27 Oct 2026 | Financial results | Financial Results for the Quarter Ended September 30, 2026 | |
| 20 Oct 2026 | Board meeting | Board Meeting | |
| 28 Aug 2026 | Report sent to shareholders | Transmission of Quarterly Financial Statements for the Period Ended June 30, 2026 | |
| 28 Aug 2026 | Financial results | Financial Results for the Half Year Ended June 30 2026 | |
| 20 Aug 2026 | Board meeting | Board Meeting | |
| 10 Jun 2026 | Management change | Re-Appointment of Chairman | |
| 10 Jun 2026 | Management change | Re-Appointment of Chief Executive Officer | |
| 02 Jun 2026 | Corporate briefing | Dissemination of Video Recording Link of Corporate Briefing Session (CBS) 2026 | |
| 25 May 2026 | Corporate briefing | Revised Presentation of Corporate Briefing Session 2026 | |
| 22 May 2026 | Corporate briefing | Presentation of Corporate Briefing Session 2026 | |
| 22 May 2026 | Corporate briefing | Corporate Briefing Session 2026 | |
| 11 May 2026 | Dividend or bonus payment | Credit of Final Cash Dividend | |
| 30 Apr 2026 | General meeting | Election of Directors | |
| 30 Apr 2026 | General meeting | Certified copy of Resolution passed at the 77th Annual General Meeting | |
| 29 Apr 2026 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended March 31, 2026 | |
| 27 Apr 2026 | Financial results | Financial Results for the Quarter Ended March 31, 2026 | |
| 23 Apr 2026 | General meeting | Ballott Paper for the Annual General Meeting | |
| 20 Apr 2026 | Board meeting | Board Meeting | |
| 08 Apr 2026 | Report sent to shareholders | Transmission of Annual Report for the Year Ended December 31, 2025 | |
| 08 Apr 2026 | General meeting | Notice of Annual General Meeting | |
| 01 Apr 2026 | General meeting | Change in Date and Time of the 77th Annual General Meeting | |
| 16 Mar 2026 | Financial results | Financial Results for the Year Ended December 31, 2025 | |
| 09 Mar 2026 | Board meeting | Board Meeting | |
| 30 Dec 2025 | Corporate briefing | ABOT | Abbott Laboratories (Pakistan) Limited Revised Presentation of Corporate Briefing Session 2025 REVISED | |
| 30 Dec 2025 | Corporate briefing | ABOT | Abbott Laboratories (Pakistan) Limited Corporate Briefing Session (CBS) REVOKED | |
| 29 Dec 2025 | Corporate briefing | Presentation of Corporate Briefing Session 2025 | |
| 26 Dec 2025 | Corporate briefing | Corporate Briefing Session 2025 | |
| 25 Nov 2025 | Management change | Appointment of Director | |
| 30 Oct 2025 | Report sent to shareholders | Transmission of Quarterly Reports for the Period Ended September 30, 2025 | |
| 29 Oct 2025 | Financial results | Financial Results for the Quarter Ended September 30, 2025 | |
| 22 Oct 2025 | Board meeting | Board Meeting | |
| 29 Aug 2025 | Report sent to shareholders | Transmission of Quarterly Account for the Period Ended June 30, 2025 | |
| 29 Aug 2025 | Management change | Resignation of Board Director | |
| 28 Aug 2025 | Financial results | Financial Results for the Quarter Ended June 30, 2025 | |
| 20 Aug 2025 | Board meeting | Board Meeting | |
| 02 May 2025 | Management change | Appointment of Director | |
| 30 Apr 2025 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended March 31, 2025 | |
| 29 Apr 2025 | Dividend or bonus payment | Credit of Final Cash Dividend | |
| 28 Apr 2025 | Financial results | Financial Results for the Quarter Ended March 31, 2025 | |
| 23 Apr 2025 | General meeting | Certified copy of Resolutions passed at the 76th Annual General Meeting | |
| 21 Apr 2025 | Board meeting | Board Meeting | |
| 25 Mar 2025 | Report sent to shareholders | Transmission of Annual Report for the Year Ended 31 December 2024 | |
| 25 Mar 2025 | General meeting | Notice of Annual General Meeting | |
| 25 Feb 2025 | Financial results | Additional Information to Financial Results for the Year Ended 31st December 2024 | |
| 20 Feb 2025 | Financial results | Financial Results for the Year Ended December 31st, 2024 | |
| 13 Feb 2025 | Board meeting | Board Meeting | |
| 03 Feb 2025 | Management change | Resignation of Board Director | |
| 17 Dec 2024 | Corporate briefing | Presentation of Corporate Briefing Session 2024 | |
| 12 Dec 2024 | Corporate briefing | Corporate Briefing Session 2024 | |
| 30 Oct 2024 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended September 30, 2024 | |
| 25 Oct 2024 | Financial results | Financial Results for the Quarter Ended September 30, 2024 | |
| 18 Oct 2024 | Board meeting | Board Meeting | |
| 28 Aug 2024 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended June 30, 2024 | |
| 26 Aug 2024 | Financial results | Financial Results for thr Quarter Ended June 30 2024 | |
| 19 Aug 2024 | Board meeting | Board Meeting | |
| 30 Apr 2024 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended March 31, 2024 | |
| 25 Apr 2024 | Financial results | Financial Results for the 1st Quarter ended March 31, 2024 | |
| 23 Apr 2024 | General meeting | Certified copy of Resolution passed at the 75th Annual General Meeting | |
| 18 Apr 2024 | Board meeting | Board Meeting | |
| 15 Apr 2024 | General meeting | Publication of Postal Ballot and Provision of Electronic Voting for Voting on Special Business | |
| 08 Apr 2024 | General meeting | Addendum to the Notice of 75th Annual General Meeting | |
| 29 Mar 2024 | Report sent to shareholders | Transmission of Annual Report for the Year Ended December 31, 2023 | |
| 29 Mar 2024 | General meeting | Notice of Annual General Meeting | |
| 22 Feb 2024 | Financial results | Financial Results for the year ended December 31, 2023 | |
| 15 Feb 2024 | Board meeting | Board Meeting | |
| 04 Jan 2024 | Administrative notice | Notice to Shareholders regarding Transfer of Shares Registrar/ Transfer Agent Services (Post Publication) | |
| 29 Dec 2023 | Administrative notice | TRANSFER OF SHARES REGISTRAR/ TRANSFER AGENT SERVICES | |
| 05 Dec 2023 | Corporate briefing | Presentation of Corporate Briefing Session 2023 | |
| 01 Dec 2023 | Corporate briefing | Notice for Briefing Session | |
| 27 Oct 2023 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended September 30, 2023 | |
| 23 Oct 2023 | Financial results | Financial Results for the Quarter Ended September 30, 2023 | |
| 16 Oct 2023 | Board meeting | Board Meeting | |
| 30 Aug 2023 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended June 30, 2023 | |
| 28 Aug 2023 | Financial results | Financial Results for the Quarter ended June 30, 2023 | |
| 21 Aug 2023 | Board meeting | Board Meeting | |
| 02 Jun 2023 | Management change | Re-Appointment of Chairman | |
| 02 Jun 2023 | Management change | Re-Appointment of Chief Executive | |
| 28 Apr 2023 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended March 31, 2023 | |
| 26 Apr 2023 | Financial results | Financial Results for the Quarter Ended March 31 2023 | |
| 20 Apr 2023 | General meeting | Election of Directors | |
| 20 Apr 2023 | General meeting | Certified copy of Resolutions passed at the 74th Annual General Meeting | |
| 19 Apr 2023 | Board meeting | Board Meeting | |
| 12 Apr 2023 | General meeting | Notice- Election of Directors | |
| 29 Mar 2023 | Report sent to shareholders | Transmission of Annual Report for the Year Ended December 31, 2022 | |
| 29 Mar 2023 | General meeting | Addendum to the Notice of Annual General Meeting | |
| 28 Mar 2023 | Report sent to shareholders | Transmission of Annual Report for the Year Ended December 31, 2022 REVOKED | |
| 28 Mar 2023 | General meeting | Notice of Annual General Meeting | |
| 22 Feb 2023 | Financial results | Financial Results for the Year Ended December 31st, 2022 | |
| 15 Feb 2023 | Board meeting | Board Meeting | |
| 23 Dec 2022 | Corporate briefing | Presentation of CBS 2022 | |
| 07 Dec 2022 | Corporate briefing | Notice for Corporate Briefing Session | |
| 28 Oct 2022 | Report sent to shareholders | Transmission of Quarterly Report for the Period Ended 2022-09-30 | |
| 26 Oct 2022 | Financial results | Financial Results for the Quarter Ended 2022-09-30 | |
| 14 Oct 2022 | Board meeting | Board Meeting | |
| 23 Sep 2022 | Dividend or bonus payment | Credit of Interim Cash Dividend | |
| 29 Aug 2022 | Financial results | Financial Results for the period ended June 30, 2022 | |
| 29 Aug 2022 | Report sent to shareholders | Transmission of Quarterly Report for the period ended June 30, 2022 | |
| 29 Aug 2022 | Financial results | Financial Results for the period ended June 30, 2022 REVOKED | |
| 26 Aug 2022 | General meeting | Certified copy of Resolutions passed at the 73rd Annual General Meeting |
Titles are the exchange’s own words. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.
By kind
- Financial results: 20
- Report sent to shareholders: 19
- Board meeting: 17
- General meeting: 17
- Corporate briefing: 14
- Management change: 8
- Dividend or bonus payment: 3
- Administrative notice: 2
Counted from the 100 notices above. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.
More on ABOT
- ABOT share price and overview
- ABOT dividend history
- Pharmaceuticals sector
- AGP announcements · AGP Limited
- BFBIO announcements · BF Biosciences Limited
- CPHL announcements · Citi Pharma Ltd.
- GLAXO announcements · GlaxoSmithKline Pakistan Limited
- HALEON announcements · Haleon Pakistan Limited
- HINOON announcements · Highnoon Laboratories Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .